NCT05198830
Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer treatment 2 recruiting NCT03801902
Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), ARCHON-1 Trial treatment 1 suspended NCT03811002
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) treatment 3 active_not_recruiting NCT04013542
Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancer treatment 1 active_not_recruiting NCT04092283
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer treatment 3 active_not_recruiting NCT04310020
Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients treatment 2 recruiting NCT04314401
National Cancer Institute "Cancer Moonshot Biobank" No drug interventions Not Available Not Available recruiting NCT04514484
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV treatment 1 active_not_recruiting NCT05624996
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-small Cell Lung Cancer treatment 3 recruiting NCT03225664
Trametinib and Pembrolizumab in Treating Patients With Recurrent Non-small Cell Lung Cancer That Is Metastatic, Unresectable, or Locally Advanced treatment 1 / 2 active_not_recruiting NCT04940299
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma treatment 2 active_not_recruiting NCT06122064
A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer No drug interventions health_services_research Not Available recruiting NCT04946279
Decision Aid for the Improvement of Decision-Making in Patients With Non-small Cell Lung Cancer No drug interventions health_services_research Not Available active_not_recruiting NCT04785287
Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies treatment 1 / 2 active_not_recruiting NCT05967533
The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors No drug interventions treatment 1 recruiting NCT04892953
Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy treatment 2 recruiting NCT04751747
Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung Cancer No drug interventions supportive_care Not Available recruiting NCT04073745
Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung Cancer No drug interventions treatment 1 recruiting NCT04514497
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer treatment 1 active_not_recruiting NCT04227028
Brigatinib and Bevacizumab for the Treatment of ALK-Rearranged Locally Advanced, Metastatic, or Recurrent NSCLC treatment 1 active_not_recruiting NCT04186988
[18F]-AraG for the Detection of T-Cell Activation in Advanced Non-small Cell Lung Cancer Patients Undergoing PD-1/PD-L1-Directed Therapy No drug interventions diagnostic 0 withdrawn NCT04701307
Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine Carcinomas treatment 2 active_not_recruiting NCT05340309
Subcutaneous Atezolizumab for the Treatment of Non-small Cell Lung Cancer treatment 2 recruiting NCT03830918
Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy treatment 1 / 2 recruiting NCT04183218
Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes No drug interventions Not Available Not Available completed NCT03637816
Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer supportive_care 2 / 3 active_not_recruiting NCT03867916
Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients No drug interventions health_services_research Not Available completed NCT05166616
Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer treatment 1 recruiting NCT04396535
Docetaxel With or Without Bintrafusp Alfa for the Treatment of Advanced Non-small Cell Lung Cancer treatment 2 terminated NCT05096663
Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) treatment 2 / 3 active_not_recruiting NCT04705025
Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung Cancer No drug interventions supportive_care Not Available terminated NCT05640765
BeWell360-CG Care Model: Health and Wellness Coaching to Support Caregivers of Patients Living With Advanced Lung Cancers No drug interventions supportive_care Not Available active_not_recruiting NCT06249282
Carfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Metastatic Non-small Cell Lung Cancer treatment 1 recruiting NCT04372927
ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy treatment 2 terminated NCT05022394
Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME Study treatment 1 / 2 withdrawn NCT04902040
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies treatment 1 / 2 recruiting NCT04505267
NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung Cancer No drug interventions treatment 1 recruiting NCT03995667
Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung Cancer No drug interventions prevention 2 terminated NCT05136846
Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer treatment 1 recruiting NCT05269381
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors treatment 1 / 2 recruiting NCT04789681
Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial prevention 2 recruiting NCT02419495
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies treatment 1 active_not_recruiting NCT03735095
Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer treatment 1 / 2 active_not_recruiting NCT05407038
Remote Monitoring With Health-Coaching for Lifestyle Changes in Patients With Lung Cancer Related Fatigue No drug interventions supportive_care Not Available active_not_recruiting NCT02955290
CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer treatment 1 / 2 recruiting NCT04971187
Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer treatment 2 terminated NCT03590054
Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies treatment 1 completed NCT03776253
Conquer Fear SUPPORT Intervention in Supporting Patients With Stage III-IV Lung or Gynecologic Cancer No drug interventions supportive_care Not Available active_not_recruiting NCT04662645
Embedded Palliative Care in Managing Symptoms in Participants With Recurrent Stage III-IV Thoracic Malignancies and Their Caregivers No drug interventions supportive_care Not Available completed NCT04428905
Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer No drug interventions supportive_care Not Available active_not_recruiting NCT04819997
A Nurse-Led Intervention for Fear of Progression in Advanced Cancer No drug interventions supportive_care Not Available active_not_recruiting NCT04857697
Effects of Probiotics on the Gut Microbiome and Immune System in Operable Stage I-III Breast or Lung Cancer supportive_care 0 completed NCT05443971
Durvalumab and Grid Therapy for Non-small Cell Lung Cancer in Progression During or After Treatment With PACIFIC Regimen treatment 2 recruiting NCT02983578
Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer treatment 2 active_not_recruiting NCT05213078
Family Caregivers in Underserved Populations Providing Complex Cancer Care No drug interventions supportive_care Not Available completed NCT05010109
Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation No drug interventions diagnostic 1 recruiting NCT03731585
Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing Treatment No drug interventions supportive_care Not Available active_not_recruiting NCT03132532
Platinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery treatment 2 completed NCT03948100
Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers No drug interventions supportive_care Not Available recruiting NCT05733000
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors treatment 2 recruiting NCT05412875
Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung supportive_care Not Available withdrawn NCT04491942
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer treatment 1 active_not_recruiting NCT06075524
Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types No drug interventions Not Available Not Available recruiting NCT03819296
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer treatment 1 / 2 recruiting NCT03902535
Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Lung Cancer Undergoing Surgery or Chemoradiation and Their Caregivers No drug interventions Not Available Not Available completed NCT04430725
Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study No drug interventions Not Available Not Available recruiting NCT06495125
Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer treatment 2 recruiting NCT05017025
Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung Cancer treatment 1 / 2 active_not_recruiting NCT02595866
Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer treatment 1 completed NCT03707574
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study No drug interventions Not Available Not Available active_not_recruiting NCT02595931
M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery treatment 1 active_not_recruiting NCT06139627
Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy No drug interventions supportive_care Not Available recruiting NCT05334329
Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors treatment 1 active_not_recruiting NCT05498389
EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer treatment 1 / 2 not_yet_recruiting NCT03939481
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer No drug interventions Not Available Not Available active_not_recruiting NCT04862195
Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology Treatment No drug interventions treatment Not Available terminated NCT05502523
The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer No drug interventions treatment Not Available suspended